Skip to main content
Daily Report

Daily Anesthesiology Research Analysis

04/04/2026
3 papers selected
43 analyzed

Analyzed 43 papers and selected 3 impactful papers.

Summary

Two randomized trials in anesthesiology report practical gains: regional anesthesia with dexmedetomidine sedation improved early postoperative recovery over general anesthesia in ambulatory breast surgery, and a modified ramped position enhanced cricothyroid membrane identification in obese patients. A prospective obstetric anesthesia study quantified the time-dependent placental transfer of sevoflurane, showing end-tidal values do not predict fetal exposure.

Research Themes

  • Optimizing ambulatory anesthesia strategies
  • Airway management and front-of-neck access in obesity
  • Maternal-fetal pharmacokinetics under general anesthesia

Selected Articles

1. Recovery quality with regional anesthesia and dexmedetomidine sedation versus general anesthesia for ambulatory breast cancer surgery: A randomized trial.

75.5Level IIRCT
Breast (Edinburgh, Scotland) · 2026PMID: 41932294

In ambulatory breast-conserving surgery, regional anesthesia with dexmedetomidine sedation yielded higher QoR-15 scores at 6 hours (median 142 vs 132), less early postoperative pain and rescue analgesia, and markedly reduced PONV compared with general anesthesia. Intraoperative hemodynamic fluctuations and hypotension episodes were fewer with regional anesthesia.

Impact: This randomized trial directly informs anesthetic choice for common ambulatory breast procedures, demonstrating clinically meaningful improvements in recovery quality and side-effect profile with a GA-sparing strategy.

Clinical Implications: For eligible breast-conserving surgeries, consider PECS and intercostal blocks with dexmedetomidine sedation to enhance early recovery, reduce PONV, and stabilize hemodynamics, while ensuring team expertise in regional techniques and monitoring for bradycardia/hypotension from dexmedetomidine.

Key Findings

  • QoR-15 at 6 h was higher with regional anesthesia plus dexmedetomidine (median 142 [136–146]) versus general anesthesia (132 [127–135]; p < 0.01).
  • Early postoperative pain was lower and rescue analgesia less frequent in the regional group (27% vs 56%; p < 0.01).
  • PONV was markedly reduced with regional anesthesia (2% vs 27%; p < 0.01).
  • Fewer intraoperative hypotension episodes and smaller hemodynamic fluctuations occurred with regional anesthesia; postoperative hypotension/bradycardia rates were similar.

Methodological Strengths

  • Randomized allocation with standardized anesthetic protocols and predefined QoR-15 endpoints.
  • Multiple clinically relevant secondary outcomes (pain, rescue analgesia, PONV, hemodynamics) assessed at 2, 6, and 24 hours.

Limitations

  • Single-center trial with modest sample size and inherent unblinding due to technique differences.
  • Short follow-up limited to 24 hours; longer-term outcomes and rare adverse events not captured.

Future Directions: Multicenter trials comparing broader breast procedures, cost-effectiveness analyses, and evaluation of longer-term patient-reported outcomes and safety are warranted.

BACKGROUND: Advances in regional anesthesia techniques and the widespread use of ultrasound guidance have enabled safe and effective anesthesia for ambulatory breast cancer surgery, eliminating the general anesthesia-associated systemic effects. We therefore compared regional anesthesia with dexmedetomidine sedation to general anesthesia on the 15-item postoperative quality of recovery (QoR-15). METHODS: Ninety-six patients scheduled for breast-conserving surgery and sentinel lymph node biopsy were randomly assigned to regional anesthesia with sedation or general anesthesia. In patients assigned to regional anesthesia, a 0.3% ropivacaine solution was used for pectoral and intercostal nerve blocks, followed by a dexmedetomidine infusion. In other patients, standardized general anesthesia was maintained with a laryngeal mask airway. The primary outcome was the QoR-15 score 6 h after surgery. Secondary outcomes included QoR-15 scores at 2 and 24 h; pain scores obtained using the numerical rating scale (NRS) at 2, 6, and 24 h; and the incidence of postoperative complications. RESULTS: At postoperative hour 6, QoR-15 scores were significantly and meaningfully higher in patients given regional anesthesia [142 (136, 146)] than those assigned to general anesthesia [132 (127, 135), p < 0.01]. Regional anesthesia patients also had significantly higher QoR-15 scores at 2 and 24 h postoperatively. Two hours after surgery, regional anesthesia patients had lower pain scores at rest and during movement, needed less rescue analgesia [13 (27%) versus 27 (56%), p < 0.01], and had fewer experienced nausea and vomiting [1 (2%) versus 13 (27%), p < 0.01]. Moreover, patients assigned to regional anesthesia had fewer episodes of hypotension and smaller hemodynamic fluctuations during skin incision. In contrast, there were no significant differences in the incidences of postoperative hypotension and bradycardia in patients randomized to regional and general anesthesia. CONCLUSIONS: Recovery quality after breast-conserving surgery combined with sentinel lymph node biopsy was better with regional anesthesia combined with dexmedetomidine sedation than with general anesthesia. Regional anesthesia also improved pain control, intraoperative hemodynamic stability, and decreased nausea and vomiting.

2. Comparison of neck-extended and modified ramped positions for locating the cricothyroid membrane in obese anesthetized patients.

65.5Level IIRCT
The American journal of emergency medicine · 2026PMID: 41932263

In anesthetized obese women, a modified ramped position combining ramping with full head extension significantly increased accurate cricothyroid membrane identification (77% vs 48%) compared with a neck-extended position, without increasing time. Anesthesiologists rated palpation as easier in the modified ramped position.

Impact: Airway emergencies in obesity carry high risk; this pragmatic randomized comparison provides actionable positioning guidance to improve front-of-neck access success.

Clinical Implications: Adopt a modified ramped position (ramp plus full head extension) when palpating the cricothyroid membrane in obese patients to increase identification accuracy before emergency front-of-neck access.

Key Findings

  • Accurate cricothyroid membrane identification was higher with modified ramped position versus neck-extended position (77% vs 48%; P = 0.002).
  • Time to locate the membrane center was similar between positions (46.0 s vs 41.0 s; P = 0.562).
  • Subjective difficulty of palpation was lower with the modified ramped position (P = 0.019).

Methodological Strengths

  • Randomized comparative design with standardized palpation technique (laryngeal handshake).
  • Clear, clinically relevant endpoints (accuracy, time, subjective difficulty) in a high-risk population.

Limitations

  • Female-only cohort may limit generalizability to male obese patients.
  • Anatomical confirmation methods beyond palpation (e.g., ultrasound or CT) were not detailed as gold standards.

Future Directions: Validate positioning benefits with ultrasound-confirmed landmarks, include male cohorts, and assess impact on emergency cricothyrotomy success and safety.

OBJECTIVE: Precise localization of the cricothyroid membrane in obese women is challenging. This randomized comparative study aimed to evaluate the neck-extended position versus the modified ramped position in terms of success rate, time required, and perceived difficulty in identifying the cricothyroid membrane in anesthetized obese female patients. METHODS: After the induction of anesthesia in 112 obese female patients, the cricothyroid membrane was identified using the laryngeal handshake technique in the neck-extended or modified ramped position. In the neck-extended position, a pillow was placed beneath the shoulders in the supine position. The modified ramped position was achieved by combining a ramped position with full head extension using a specialized pillow. The success rate of accurate identification of the cricothyroid membrane, time required to locate the cricothyroid membrane center, and the subjective difficulty of cricothyroid membrane palpation were recorded. RESULTS: The success rate of accurate identification of the cricothyroid membrane was significantly higher in the modified ramped position than in the neck-extended position (77% vs. 48%, respectively; P = 0.002). The time required for localization of the cricothyroid membrane center did not differ between the neck-extended and modified ramped positions (46.0 [23.2] s vs. 41.0 (15.0) s, respectively; P = 0.562). The subjective difficulty of cricothyroid membrane palpation as perceived by anesthesiologists was significantly lower in the modified ramped position than in the neck-extended position (P = 0.019). CONCLUSION: The modified ramped position facilitated accurate identification of the cricothyroid membrane and reduced the difficulty of cricothyroid membrane palpation in anesthetized obese female patients compared with the neck-extended position.

3. Time-dependent placental transfer of sevoflurane during cesarean delivery under general anesthesia: a prospective observational study.

60.5Level IIICohort
International journal of obstetric anesthesia · 2026PMID: 41932008

Among 16 elective cesarean deliveries under general anesthesia, fetal sevoflurane exposure (feto-maternal ratio ≈0.2) rose by ~52% per additional minute between induction and delivery. End-tidal and maternal blood sevoflurane did not predict fetal blood levels, and neonatal Apgar scores and umbilical pH were reassuring.

Impact: This study provides quantitative, time-resolved evidence linking induction-to-delivery interval to fetal volatile anesthetic exposure, challenging reliance on end-tidal monitoring as a proxy for fetal drug levels.

Clinical Implications: When general anesthesia is necessary for cesarean delivery, streamline induction-to-delivery workflows to limit fetal sevoflurane exposure; avoid assuming end-tidal values reflect fetal levels and prioritize obstetric-anesthesia coordination.

Key Findings

  • Feto-maternal sevoflurane ratio averaged 0.20 ± 0.16 and increased with induction-to-delivery time (P < 0.001).
  • Each additional minute between induction and delivery increased estimated fetal exposure by 52%.
  • End-tidal and maternal blood sevoflurane concentrations did not predict fetal blood levels.
  • All neonates had Apgar ≥8 at 10 minutes and no acidosis; fetal sevoflurane levels showed no large effects on Apgar or umbilical pH.

Methodological Strengths

  • Prospective sampling with paired maternal–umbilical blood and analytic quantification via headspace GC–MS.
  • Clear primary hypothesis testing of time–exposure relationship with clinically relevant neonatal checks.

Limitations

  • Small single-center cohort (n=16) limits generalizability and power for neonatal outcome associations.
  • Observational design cannot control for all intraoperative variables influencing transfer.

Future Directions: Larger multicenter cohorts to validate kinetics across volatile agents and examine dose–response links to neonatal outcomes; modeling to inform practical time thresholds.

BACKGROUND: General anesthesia for cesarean delivery requires balancing adequate maternal anesthetic depth against fetal drug exposure. The relationship between induction-to-delivery time, maternal anesthetic concentration, and fetal sevoflurane exposure remains incompletely characterized. METHODS: In this prospective observational study, 16 women undergoing elective cesarean delivery under general anesthesia were enrolled. Paired maternal and umbilical blood samples were analyzed by headspace gas chromatography-mass spectrometry at delivery. Our primary investigation was the correlation between induction-to-delivery time and feto-maternal ratio. RESULTS: Mean induction-to-delivery time was 3.3 ± 1.1 min (range 1.5-5.3). Mean feto-maternal ratio was 0.2 ± 0.16. Induction-to-delivery time correlated with feto-maternal ratio (P < 0.001). Each additional minute increased fetal exposure by 52%. Neither end-tidal concentration nor maternal blood sevoflurane levels predicted fetal blood concentrations. In exploratory analysis, fetal sevoflurane concentration showed no evidence of large effects on Apgar scores (r = -0.06, P = 0.830) or umbilical pH (r = 0.41, P = 0.110). All neonates achieved an Apgar score of at least 8 at 10 min; no acidosis occurred. CONCLUSIONS: Induction-to-delivery time was strongly associated with fetal sevoflurane exposure. End-tidal monitoring reflects maternal anesthetic depth but does not predict fetal drug levels. Given the limited sample size, the clinical implications for neonatal outcomes remain uncertain. Minimizing induction to delivery time may reduce fetal exposure, but this requires confirmation in larger studies.